UA97232C2 - Isolated antibody that binds to human monocyte chemoattractant protein-1 (mcp-1) - Google Patents
Isolated antibody that binds to human monocyte chemoattractant protein-1 (mcp-1)Info
- Publication number
- UA97232C2 UA97232C2 UAA200713135A UAA200713135A UA97232C2 UA 97232 C2 UA97232 C2 UA 97232C2 UA A200713135 A UAA200713135 A UA A200713135A UA A200713135 A UAA200713135 A UA A200713135A UA 97232 C2 UA97232 C2 UA 97232C2
- Authority
- UA
- Ukraine
- Prior art keywords
- mcp
- binds
- isolated antibody
- chemoattractant protein
- monocyte chemoattractant
- Prior art date
Links
- 101000897480 Homo sapiens C-C motif chemokine 2 Proteins 0.000 title abstract 2
- 102000046768 human CCL2 Human genes 0.000 title abstract 2
- 101100504320 Caenorhabditis elegans mcp-1 gene Proteins 0.000 title 1
- 101710155857 C-C motif chemokine 2 Proteins 0.000 abstract 2
- 102000000018 Chemokine CCL2 Human genes 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to an isolated antibody that binds to human monocyte chemoattractant protein-1 (MCP-1), a pharmaceutical composition comprising the antibody, a method for producing the antibody, and to use thereof for the treatment of MCP-1 dependent disorders.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68265405P | 2005-05-19 | 2005-05-19 | |
| PCT/US2006/019627 WO2006125202A2 (en) | 2005-05-19 | 2006-05-19 | Anti- mcp-1 antibodies, compositions, methods and uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA97232C2 true UA97232C2 (en) | 2012-01-25 |
Family
ID=46801750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200713135A UA97232C2 (en) | 2005-05-19 | 2006-05-19 | Isolated antibody that binds to human monocyte chemoattractant protein-1 (mcp-1) |
Country Status (3)
| Country | Link |
|---|---|
| GT (1) | GT200600212A (en) |
| HN (1) | HN2006018793A (en) |
| UA (1) | UA97232C2 (en) |
-
2006
- 2006-05-19 HN HN2006018793A patent/HN2006018793A/en unknown
- 2006-05-19 GT GT200600212A patent/GT200600212A/en unknown
- 2006-05-19 UA UAA200713135A patent/UA97232C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HN2006018793A (en) | 2011-04-25 |
| GT200600212A (en) | 2006-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1122238T1 (en) | NOVEL 1-NAPHTHYL-3-AZADICYCLO[3.1.0]HEXANE: PREPARATION AND USE FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | |
| NO20083895L (en) | Anti-IGF-1R human monoclonal antibody formulation | |
| TW200728466A (en) | Antibody molecules having specificity for human IL-6 | |
| JO2576B1 (en) | Antibodies | |
| TW200716646A (en) | (S)-N-methylnaltrexone | |
| UA92505C2 (en) | Anti-cd3 antibody formulations | |
| TW200505942A (en) | Antibody molecules having specificity for human IL-1β | |
| EP2514764A3 (en) | Antibody molecules which bind IL-17A and IL-17F | |
| CY1112238T1 (en) | ANTI-KINESIN SUSPENSIONS AND METHODS OF USING THESE | |
| MX2009008104A (en) | Hepcidin, hepcidin antagonists and methods of use. | |
| EP2535355A3 (en) | Antibodies against CD38 for treatment of multiple myeloma | |
| IL226717A0 (en) | Humanized anti-beta7 antagonists and uses therefor | |
| WO2010021874A3 (en) | Engineered anti-il-13 antibodies, compositions, methods and uses | |
| TW200714290A (en) | Anti-M-CSF antibody compositions having reduced levels of endotoxin | |
| MX272108B (en) | Substituted heterocycles. | |
| MX2010000098A (en) | Polycyclic guanine derivatives and use thereof. | |
| ATE453642T1 (en) | SUBSTITUTED PHENYLAMINOPYRIMIDINES | |
| IL209338A0 (en) | Pharmaceutical compositions containing anti-cd-3 antibodies | |
| DE60321041D1 (en) | ANTIBODY TO CANCERANT TMEFF2 AND ITS APPLICATIONS | |
| WO2004031105A3 (en) | Use of a33 antigens and jam-it | |
| UA99716C2 (en) | Antibody that specifically binds to human il-17 receptor a (il-17ra) | |
| TW200716172A (en) | Pharmaceutical compositions for treating lower motor neuron diseases | |
| WO2007025146A3 (en) | Balsalazide formulations and manufacture and use thereof | |
| MX2007010484A (en) | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases. | |
| UA97232C2 (en) | Isolated antibody that binds to human monocyte chemoattractant protein-1 (mcp-1) |